Use in Specific Populations Pregnancy: Advise females of potential risk to a fetus especially during the second and third trimesters Lactation: FARXIGA is not recommended when breastfeeding FARXIGA is indicated: as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either established cardiovascular (CV) disease or multiple CV risk factors to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney disease at risk of progression FARXIGA is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus

At Cape Fear Physical Medicine and Rehab, we offer: A Holistic Approach: We dont just hand you a prescription
BI is clearly betting on systems-level disease modification, not incremental weight reduction
Peptides: What They Are, What We Know, and Why BPC-157 Is Worth Talking About Orie Quinn Sep 29, 2025 3 min read When most people hear the word peptides , their first thought is skincare ads promising fewer wrinkles
Relumins Glutathione Spray Vials - New Advanced Formula are taken orally, when taken as a liquid, glutathione is absorbed rapidly for high performance skin whitening, antioxidant activity, anti-aging and increased fat metabolism
How long does it take to see results with retatrutide or tirzepatide